Famotidine impact on weight gain associated with olanzapine
Not Applicable
- Conditions
- Condition 1: Schizophrenia disorder. Condition 2: bipolar disorder. Condition 3: Major deppresion disorder.SchizophreniaBipolar affective disorderDepressive episode
- Registration Number
- IRCT2015052022349N1
- Lead Sponsor
- Ahvaz Jundishapur University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 44
Inclusion Criteria
Patients 20 to 55 years with psychiatric disorders; Non-pregnant;No history of medical conditions increase weight
Exclusion criteria: Patients who have serious health problems including liver or kidney disease;Use of other medications with potential weight gain ; Patients who have a body mass index greater than 30
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Weight.BMI. Timepoint: week 0,2,4,6,8 during intervention. Method of measurement: Weight, balance(kg),BMI,The ratio of weight to height squared.
- Secondary Outcome Measures
Name Time Method